Locus 137: FUT2 (19q13.33)
EA = effect allele; OA = other allele; EAF = frequency of effect allele;
| Summary of biological annotations |
| SNP | rs601338 |
| Chromosomal location | Chr19: 53,898,486 (19q13.33) |
| Gene (distance) | FUT2 (0) |
| Predicted causal gene | FUT2 |
| Gene/protein classification | - |
| Metabolite (Pathway) | ADSGEGDFXAEGGGVR* (Fibrinogen cleavage peptide; Peptide) ADpSGEGDFXAEGGGVR* (Fibrinogen cleavage peptide; Peptide) |
| Biochemical locus-metabolite relationship | FUT2 is located at the secretor locus and encodes a fucosyltransferase which determines the secretion status of the ABO antigens [7876235]. FUT2 influences von Willebrand Factor levels, perhaps by altering its glycosylation pattern and protecting it from susceptibility to ADAMTS13-mediated proteolysis. As part of the coagulation cascade, von Willebrand Factor effects rates of fibrinogen cleavage [17894864]. Ratio interpretation: likely substrate/product pair. ALPL plausibly affects phosphorylation state of fibrinogen ('activity') |
| eQTL associations | FUT2 (S), NTN5 (S), RASIP1 (S), SULT2B1 (F) † |
† F = adipose tissue; S = skin cells; L = lymphoblastoid cells; H = liver cells;
| Medical information |
| Complex trait associations | Cholesterol, total [20686565]; Crohn's disease [20570966,23128233]; Liver enzyme levels (alkaline phosphatase) [22001757]; Liver enzyme levels (gamma-glutamyl transferase) [22001757]; Obesity-related traits [23251661]; Vitamin B12 levels [18776911] |
| Known metabolite associations | ADpSGEGDFXAEGGGVR*/ADSGEGDFXAEGGGVR* [21886157] |
| Inborn error of metabolism | - |
| Pharmacological information |
| ChEMBL ID | - |
| Drug information |
-
|
| Locus information for top associated metabolite |
HapMap2 imputation | 1KGP imputation |

